Plné znění - 2/2008 Sb. m. s.

Ministerstvo zahraničních xxxx xxxxxxx, xx xxx 16. xxxxxxxxx 2007 xxxx generálním xxxxxxxxx UNESCO, xxxxxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx sportu¹⁾, xxxxxxxx xxxxxxxxx xxxxxx xxxxx Přílohy I - Xxxxxxx zakázaných látek x xxxxx dopingu.

Xxxxxxx X xxxxxxxxx x xxxxxxxx v xxxxxxx x článkem 34 xxxx. 3 Úmluvy xxx 1. ledna 2008 a xxxxx xxxx vstoupila x xxxxxxxx x xxx Xxxxxx xxxxxxxxx. Xxxx xxxxxx Xxxxxxx X x xxxxxxxx přestává xxxxxx Xxxxxxx X Xxxxxxxxxxx xxxxxx proti xxxxxxx xx sportu xx xxxxx xxx xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. x. s.

Xxxxxxxx xxxxx Xxxxxxx X x xxxx xxxxxxx xx českého xxxxxx xx xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX XXXXX

Xxxxxxxxxx xxxxx jsou xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX STEROIDY (XXX):

x. Xxxxxxxx * XXX, zahrnující:

1-androstendiol (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-norandrostendiol); xxxxxxxxxx; xxxxxxxx; xxxxxxx (androsta-1,4-dien-3,17-dion); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-metyl-5α-androst-2-en-17β-ol); xxxxxxxxxxx; xxxxxxxxxxxxx (19-nor-17α-pregn-4-en-17-ol); xxxxxxxxxxxxxx; xxxxxxxxxx; furazabol (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); gestrinon; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; xxxxxxxxx; xxxxxxxxxx; mesterolon; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; methandriol; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); methyl-1-testosteron (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxxxxxxxxxx; xxxxxxxxx; nandrolon; 19-norandrostendion (xxxx-4-xx-3,17-xxxx); norboleton; norethandrolon; xxxxxxxxxxxx; xxxxxxxx; oxandrolon; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; xxxxxxxxxx; xxxxxxxxx; 1-xxxxxxxxxxx (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); xxxxxxxxx x xxxxx látky x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

b. Xxxxxxxxx ** AAS:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), dihydrotestosteron, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX), testosteron x xxxxxxxxxxx xxxxxxxxxx x xxxxxxx:

5α-androstan-3α,17α-diol androst-5-en-3β,17α-diol

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

androst-5-en-3β,17α-diol 19-norandrosteron

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17β-xxxx

X xxxxxxxxx, xxx může xxxx produkovat xxxxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx, xxxx se xxx xx xx, že Xxxxxx xxxxxxxx xxxx Xxxxxxxxx xxxxx x xxxx xxxxxx pozitivní Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxx xx koncentrace Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx nebo xxxxxxxxxxx a/nebo xxxx xx xxxxxxxx xxxx xxxxxxxxx xxxxx ve Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx xxx, xx xxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx. Xxxxxx se xxx za to, xx Xxxxxx obsahuje Xxxxxxxxx xxxxx x xxxxxxx xxxxxxx, pokud Xxxxxxxxx xxxxxxx, že xx koncentrace Xxxxxxxx xxxxx xxxx jejích xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxxxxxx xxxx xxxxxxxxxxxx xxxxxx.

Bude xx xxx xx xx, xx Xxxxxx Xxxxxxxxx obsahuje Xxxxxxxxx xxxxx x xxxxxxxxx xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx xx všech xxxxxxxxx a při xxxxxxxxx xxxxxxxxxxx, pokud xxx xxxxx spolehlivé xxxxxxxxxx metody (xxxx. XXXX) xxxxxxxx, že xx Zakázaná xxxxx xxxxxxxxxx původu. V xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

Xxxx xx xxxxxxx výsledku analýzy xxxxxxxx xxxxxxxxxxx od xxxxxxx hodnot, xxxxx xx xxxxxxxx vyskytují x lidí x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx exogenní xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx použití Xxxxxxxx xxxxx, xxxx xxxx. porovnání x xxxxxxxxxxx xxxxxxxxxxxx steroidními xxxxxxx, nebo xxxx xxxxxxxxx xxxxxxxxx xxxxx X/X xxxxx než xxxxx (4) xx xxxxx (1) a xxxxx spolehlivá xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx původ xxxxx, provede xxxxxxxxx Xxxxxxxxxxxxx organizace další xxxxxxx porovnáním výsledků xxxxxxxxxx testů xxxx xxxxxxxxxx xxxxxxxxxx xxxxx.

Xx-xx vyžadováno xxxxxx xxxxx xxxxxxx, pak xxxxxxxx bude laboratoří xxxxxx xxxx neobvyklý x xx xxxx xxxxxxxxx. Xxxxx xxxxxxxxx xxxxxxx, xx xxxxxxx xxxxxxxxxx xxxxxxxxxx metody (xxxx. IRMS) exogenní xxxxx Xxxxxxxx látky, xxxx nutné xxxxxxxx xxxxx xxxxxxx, x xxxx xx xxx xx to, xx Xxxxxx obsahuje Xxxxxxxxx xxxxx. Xxxxx nebyla xxxxxxx spolehlivá xxxxxxxxxx xxxxxx (např. IRMS) x nejsou k xxxxxxxxx minimálně 3 xxxxxxxxx xxxxx, bude xxxxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx tím, že xxxx xxxxxxxxxx Antidopingovou xxxxxxxxxx x xxxxxxxxxxxxx 3 xxxxxxxx xxxxxxx xxxxxxxx bez xxxxxxxxxxx xxxxxxxx. Výsledek, který xxxxxxxxxx tuto xxxxxxxxxxxxxx xxxxxx, xxxx xxxxxx xxxx neobvyklý. Xxxxx xxxxxxxxxxxxxx xxxxxx Sportovce, xxxxxxxx xxxxxxxxxx testy, xxxx xxxxxxxxxxxx xxxxxxxx, xxxx se xxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx xxxxx.

X xxxxxxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx xxxx xxx x xxxx trvale xxxxxxx xxxxxxxx endogenního xxxxxx xx velice xxxxxx koncentracích (xx/xx). Xxxxx xxxxxxxxx xxxxxx xxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. IRMS) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx látky, může xxx provedeno xxxxx xxxxxxx xxxxxxxxxx následného xxxxx (xxxxxxxxxx xxxxx).

Xxxxx laboratoř xxxxxxxxx Xxxxxxxxx laboratorní nález 19-xxxxxxxxxxxxxxx, bude se xx xxxxxxxxx xx xxxxxxx x xxxxxxxxxxx xxxxx exogenního původu Xxxxxxxx látky. V xxxxxxx xxxxxxx není xxxxx provádět xxxxx xxxxxxx.

V xxxxxxx, xx Sportovec xxxxxx xxxxxxxxxxxxx xxx dalších xxxxxxxxx, bude se xxx xx to, xx Vzorek Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx.

2. Ostatní xxxxxxxxxx xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx modulátory androgenových xxxxxxxxx (SARM), tibolon, xxxxxxx, xxxxxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx.

X2. XXXXXXX A XXXXXXXX XXXXX

Xxxxxxxxxxx xxxxx x xxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Xxxxxxxxxxxx (EPO);

2. Růstový xxxxxx (xXX), insulinu xxxxxxx xxxxxxx xxxxxxx (xxxx. XXX-1), xxxxxxxxxx růstové xxxxxxx (MGF);

3. Xxxxxxxxxxxxx (např. XX, xXX), zakázané xxx x xxxx;

4. Xxxxxxxx;

5. Kortikotropiny

x xxxxx xxxxx x podobnou chemickou xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

Xxxxx Xxxxxxxxx xxxxxx prokázat, xx koncentrace byla xxxxxxxxx xxxxxxxxxxxxx či xxxxxxxxxxxx xxxxxx, xxxx xx xxx xx xx, že Vzorek xxxxxxxx Xxxxxxxxx xxxxx (xxx xx xxxxxxx xxxx) x xxxxxxxxx, xxx xxxxxxxxxxx Xxxxxxxx xxxxx nebo xxxxxx xxxxxxxxxx xx xxxxxxxxxx x/xxxx xxxxxxxxx xxxxxx xx Xxxxxx Sportovce xxxxxxx xxxxxxxx hodnoty xxxxxxxx xxxxxxxx u xxxx xxx, že xxxxxxxxxxxx xxxxxxxx endogenní xxxxxxxx.

Xxxxx xxxxxxxxx xxxxxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx, xx Xxxxxxxx xxxxx xx xxxxxxxxxx původu, xxxx xx xxx xx xx, xx Xxxxxx obsahuje Zakázanou xxxxx x xxxx xxxxxxx Xxxxxxxxx laboratorní xxxxx.

X3. XXXX-2 AGONISTÉ

Všichni xxxx-2 xxxxxxxx včetně xxxxxx X- x X-xxxxxxx jsou xxxxxxxx.

Xxxxxxxx jsou xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxxx, xxx xxxxx xx xxx inhalaci xxxxx udělení xxxxxxxx xxxxxxxxxxxx výjimky.

I xxxx byla xxxxxxx xxxxxxxx xxxxx terapeutické xxxxxxx, bude xxxxx xxxxxxxxxxx (xxxxx xxxx xxxxxxxxxx) xxxxx než 1000 nanogramů v 1 mililitru xxxx xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx xxxxx, pokud Xxxxxxxxx xxxxxxxxx, xx xxxxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxx x xxxxxxxx.

X4. XXXXXXXXXXX X MODULÁTORY HORMONŮ

Xxxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Inhibitory xxxxxxxx, xxxxxxxxxx:

2. Selektivní xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (SERM), xxxxxxxx:

3. Xxxxxxx xxxxxxxxxxxxxx látky xxxxxxxxxx:

4. Xxxxx modifikující xxxxxx xxxxxxxxxx včetně xxxxxxxxxx xxxxxxxxxx, xxx xx x omezením xxxxx xx xx.

X5. XXXXXXXXX X XXXXXXX MASKOVACÍ XXXXX

Maskovací látky xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, epitestosteron, xxxxxxxxxx, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, xxxxxxxxxx), xxxxxxxxxxxxxxx (xxxx. albumin, xxxxxxx, xxxxxxxxxxxxxxxxx) x xxxxx xxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxx xxxxxxxx:

Acetazolamid, amilorid, xxxxxxxxx, xxxxxxxxx, chlortalidon, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, spironolakton, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), xxxxxxxxxx x xxxxx xxxxx x podobnou xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx (xxxxx xxxxxxxxxxxx, který není xxxxxxxx).

* Terapeutická xxxxxxx xxxx platná, xxxxx xxx Xxxxxxxxx xxxxxxxx diuretika xx xxxxxxx x xxxxxxxx xxxx xxxxxxxxxxx xxxxxxxx xxxx Zakázané xxxxx (xxxxx).

X1. XXXXXXXXX XXXXXXX XXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

X2. XXXXXXXX X XXXXXXXXX MANIPULACE

X3. XXXXXX XXXXXX

Xxxxxxxxxxxxxx xxxxxxx xxxxx, xxxx, xxxxxxxx elementů, nebo xxxxxxxxxx exprese xxxx, xxxxx xxxx schopnost xxxxxx xxxxxxxxx xxxxx, xx xxxxxxxx.

X6. XXXXXXXXXXX

Xxxxxxx xxxxxxxxxxx (xxxxxx xxxx xxxxxx xxxxxxxxxx optických (X- x L-) xxxxxxx) xxxx zakázaná, x výjimkou derivátů xxxxxxxxx x případě xxxxxx místního xxxxx x xxxxxxxxxxx zahrnutých xx Xxxxxxxxxxxxxx programu xxx xxx 2008.

Xxxxxxxxxxx xxxxxxxx:

Adrafinil, xxxxxxxxx**, amfepramon, amfetaminil, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxxx****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, heptaminol, isomethepten, xxxxx***, xxxxxxxxxxx, xxxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxx (D-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, methylfenidát, xxxxxxxx, xxxxxxxxx, niketamid, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, parahydroxyamfetamin, xxxxxxx, xxxxxxxxxxx, x-xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, selegilin, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx x další látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx příklady v xxxxx oddíle bude xxxxxxxxxx za specifickou xxxxx xxxxx, xxxxx Xxxxxxxxx xxxxxxx, xx xxxx xxxxxxxxx dostupnost x xxxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxx neúmyslné xxxxxxxx antidopingových xxxxxxxx, xxxx xx x xxx menší xxxxxxxxxxxxxxx, xx xxxx xxxxxxx xxxxxxxx xxxx dopingová xxxxx.

X7. XXXXXXXXX

Následující xxxxxxxxx xxxx zakázaná:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x jeho deriváty, xxxxxxxxxxx, xxxxxxx, morfin, xxxxxxxx, oxymorfon, pentazocin, xxxxxxx.

X8. XXXXXXXXXXX

Kanabinoidy (xxxx. xxxxx, marihuana) xxxx xxxxxxxx.

S9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx glukokortikosteroidy xxxxxxxx xxxxxx, xxxxxxxx, xxxxxxxxxx xxxx nitrosvalovou xxxxxxxx xxxx xxxxxxxx. Xxxxxx xxxxx vyžaduje xxxxxxxxxxxxx xxxxxxx.

Jiné xxxxxxx xxxxxxxx xxxxxxxx (xxxxxxxxxxxx, do xxxxx xxxxxx, xx xxxxx xxxxxx, xxxxxxxxxx, xx xxxx) x inhalační xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxxx s xxxxxxxx xxxx xxxxxxxxx.

Xxxxxxx xxxxxxxxx podávané xx potíže xxxxx (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), xxxx, xxxxx, xxxx, potíže xxxxx řitního xxxxxx, xxxxxxxx xxx x xxxxx xxxxxx zakázané x xxxxxxxxxx xxxxxx xxxxx xxxxxxxxxxxx xxxxxxx.

X1. XXXXXXX

Alkohol (xxxxxx) xx zakázaný xxxxx Xxx xxxxxxx x xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx xxxx provádět xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx xxxx. Xxxxxxx xxxxxxx pro xxxxxxxx xxxxxxxxxxx pravidla (xxxxxxxxxxxxx xxxxxxx) xx xxx xxxxxx xxxxxxxx xxxxxxx x xxxxxxxxx.

∙ Xxxxxxxxxxxx sport (FIA) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX) (0.20 x/x)

∙ Xxxxxxxxxxx (XXXX, XXX) (0.10 x/x)

∙ Moderní pětiboj (XXXX) xxx xxx xxxxxxxxxx xx xxxxxxxx (0.10 g/l)

∙ Motocyklový xxxxx (XXX) (0.10 x/x)

∙ Vodní motorismus (XXX) (0.30 g/l)

∙ Xxxxxxx (IPC) (0.10 g/l)

X2. BETA-BLOKÁTORY

Pokud xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx jsou xxxxxxxx xxxxx Xxx xxxxxxx x xxxxxxxxxxxxx sportech.

∙ Xxxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx (XXXX)

∙ Boby (XXXX)

∙ Bridž (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Xxxxxxxx (XXXX) - "xxxxx xxxx" - xxx xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX)

∙ Xxxxxxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Xxxx soutěž)

∙ Xxxxxxxx (FIS) - skoky xx xxxxxx x akrobatické xxxxxxxx-xxxxx x U-rampa, x snowboard U-rampa x "xxx xxx"

∙ Xxxxxxx xxxxxxx (XXXX) - xxx xxxxxxxxxx xx xxxxxxxx

∙ Xxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx x obdobné xxxxxx (XXXX, IPC "xxxxx")

∙ Xxxxxxx (ISSF, XXX) (xxxxxxxx xxxx Xxxx xxxxxx)

∙ Xxxxx xxxxxxxxxx (XXX)

∙ Xxxxx (FILA)

Xxxx-xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx:

Xxxxxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, celiprolol, xxxxxxx, xxxxxxxxx, karvedilol, xxxxxxxxx, xxxxxxxxxxx, metipranolol, metoprolol, xxxxxxx, oxprenolol, xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx xx s xxxxxxxx xxxxx na xx

"Xxxxxxxxxx látky"* xxxx xxxxxxxxxxx níže:

∙ Xxxxxxx Xxxx-2 xxxxxxxx x xxxxxxxx, xxxxx xxxxxxxxxxx (xxxxxxx xxxx xxxxxxxxxxx) při xxxxxxxx xxxxxx xxx 1000 ng/ml xxxx x clenbuterolu (zařazen xx xxxxxxx X 1.2 Ostatní anabolické xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, xxxxxxxxxxx, krotetamid, xxxxxxx, etamivan, xxxxxxxxxxx, xxxxxxxxxxxxx, haptaminol, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, meklofenoxát, p-metylamfetamin, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxx a xxxxxxx xxxxxxx xxxxxxxxxxx neuvedená xxxxxxxx x oddíle X6, xxx xxxxx Xxxxxxxxx xxxxxxx, že xxxxxxx xxxxxxxx xxxxxxx x xxxxxx X6;

∙ Kanabinoidy;

∙ Xxxxxxx Glukokortikosteroidy;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"X Seznamu xxxxx xxx xxxxxxxxxxx xxxxxxxxxx xxxxx, xxxxx xxxxxxxx xxxxxxxx neúmyslné xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx xxxx všeobecně xxxxxxxx x xxxxxxx xxxxxxxxx přípravcích, xxxx x nichž je xxxxx xxxxxxxxxxxxxxx, xx xxxxx xxxxxxx xxxxxxxx xxxx xxxxxxxxx činidla." Xxxxxxxx xxxxxxxxxxxxxxx pravidla xxxxxxxxxx xxxxxxxx xxxxx xxxx xxxxxxxx xxxxxxx xxxxxx xx předpokladu, xx "...Sportovec může xxxxx prokázat, xx Xxxxxxx xxxxxxxxxx xxxxx xxxxxx zamýšleno xx xxxxxxx xxxxxxxxxxx výkonu...".

Xxxxxx xxxxxxx č. 2/2008 Xx. x. x. xxxxx účinnosti xxxx 31.1.2008.

Xxxxxx xxxxxxx x. 2/2008 Sb. x. x. xxx xxxxxx xxxxxxx předpisem č. 8/2009 Sb. m. s. x xxxxxxxxx xx 7.2.2009.

Znění xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, pokud xx xxxx xxxxxx derogační xxxxx shora uvedeného xxxxxxxx xxxxxxxx.